Pharma

By Jonah Comstock January 19, 2017
Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin. The clearance is for prescription use, but includes two versions of the app: Go Dose, for patients, and Go Dose Pro, for healthcare providers. "...
By Jonah Comstock January 13, 2017
In 2016, we rounded up pharma news in the first, second, and third quarter of the year. Pharma news in the fourth quarter of 2016 mostly fit into two buckets: clinical trial data collection and chronic condition management. The latter focused especially on the diabetes and chronic respiratory disease spaces. Read on below for Q4 2016 news from a number of pharma companies from around the world....
By Heather Mack January 9, 2017
Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform. The non-exclusive partnership, developed and branded by both companies, will combine Glooko’s digital capabilities and Novo Nordisk’s deep knowledge of diabetes. Glooko offers a mobile, cloud-based platform for people with diabetes to track and...
By Jonah Comstock January 5, 2017
Cambridge-based MC10, which makes paper-thin adhesive health sensors, and Belgium-based pharma company UCB have completed the Parkinson's study they began in 2014 and are aiming to publish the results later this year, the two companies announced. The study used MC10's adhesive sensors to collect movement data on Parkinson's patients, combined with patient-reported outcomes and neurological...
By Jonah Comstock December 14, 2016
Exco InTouch, a Nottingham, England-based clinical trial technology vendor responsible for powering early, influential mobile-enabled trials, has been acquired. ERT, a 45-year-old global clinical trial services company, purchased Exco last week for an undisclosed amount. While both companies provide technology and services to support clinical trials, their focus areas are different, with ERT...
By Heather Mack December 12, 2016
Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s disease.  The study, which began in 2014, used Akili’s screening technology called AD Screen. The program targets the brain's interference processing system and then uses an algorithm to deploy a...
By Jonah Comstock December 5, 2016
Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aptiom, a drug meant to reduce seizures in people with epilepsy. “We believe that incorporating digital health technologies into traditional treatment paradigms has the potential to inform and enhance best practices and further empower...
Sponsored by
By Validic November 28, 2016
By: Jennifer Plumer, Director of Market Development, Validic So you’ve decided to include digital health devices in your trial. While that’s a great step to take as an organization, and an important step towards innovating the R&D process, it’s just the beginning.   You now have to select a device that will best suit the needs of both the trial and the patient and think through nuances with...
By Heather Mack November 21, 2016
When will Novartis and Google begin testing the autofocus contact lens they have been developing? Well, there’s still no clear date in sight. The pharmaceutical company announced late last week they had done away with a 2016 goal of testing a smart contact lens for people with nearsightedness, telling Reuters, “It is too early to say when exactly human clinical trials for these lenses will begin...
By Jonah Comstock November 17, 2016
Correction: A previous version of this article misstated the adherence figure.  Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma. “This...